• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酵母中多聚谷氨酰胺毒性的监测。

Monitoring polyglutamine toxicity in yeast.

机构信息

Boston Biomedical Research Institute, 64 Grove Street, Watertown, MA 02472, USA.

出版信息

Methods. 2011 Mar;53(3):232-7. doi: 10.1016/j.ymeth.2010.12.001. Epub 2010 Dec 6.

DOI:10.1016/j.ymeth.2010.12.001
PMID:21144902
Abstract

Experiments in yeast have significantly contributed to our understanding of general aspects of biochemistry, genetics, and cell biology. Yeast models have also delivered deep insights in to the molecular mechanism underpinning human diseases, including neurodegenerative diseases. Many neurodegenerative diseases are associated with the conversion of a protein from a normal and benign conformation into a disease-associated and toxic conformation - a process called protein misfolding. The misfolding of proteins with abnormally expanded polyglutamine (polyQ) regions causes several neurodegenerative diseases, such as Huntington's disease and the Spinocerebellar Ataxias. Yeast cells expressing polyQ expansion proteins recapitulate polyQ length-dependent aggregation and toxicity, which are hallmarks of all polyQ-expansion diseases. The identification of modifiers of polyQ toxicity in yeast revealed molecular mechanisms and cellular pathways that contribute to polyQ toxicity. Notably, several of these findings in yeast were reproduced in other model organisms and in human patients, indicating the validity of the yeast polyQ model. Here, we describe different expression systems for polyQ-expansion proteins in yeast and we outline experimental protocols to reliably and quantitatively monitor polyQ toxicity in yeast.

摘要

酵母实验极大地促进了我们对生物化学、遗传学和细胞生物学一般方面的理解。酵母模型还深入了解了人类疾病的分子机制,包括神经退行性疾病。许多神经退行性疾病与蛋白质从正常和良性构象转化为与疾病相关的毒性构象有关,这一过程称为蛋白质错误折叠。具有异常扩展的多聚谷氨酰胺(polyQ)区域的蛋白质错误折叠会导致几种神经退行性疾病,如亨廷顿病和脊髓小脑共济失调。表达 polyQ 扩展蛋白的酵母细胞重现了 polyQ 长度依赖性聚集和毒性,这是所有 polyQ 扩展疾病的标志。在酵母中鉴定 polyQ 毒性的修饰因子揭示了导致 polyQ 毒性的分子机制和细胞途径。值得注意的是,酵母中的一些发现也在其他模式生物和人类患者中得到了重现,表明了酵母 polyQ 模型的有效性。在这里,我们描述了酵母中 polyQ 扩展蛋白的不同表达系统,并概述了实验方案,以可靠和定量地监测酵母中的 polyQ 毒性。

相似文献

1
Monitoring polyglutamine toxicity in yeast.酵母中多聚谷氨酰胺毒性的监测。
Methods. 2011 Mar;53(3):232-7. doi: 10.1016/j.ymeth.2010.12.001. Epub 2010 Dec 6.
2
Chaperonin TRiC promotes the assembly of polyQ expansion proteins into nontoxic oligomers.伴侣蛋白TRiC促进多聚谷氨酰胺扩展蛋白组装成无毒寡聚体。
Mol Cell. 2006 Sep 15;23(6):887-97. doi: 10.1016/j.molcel.2006.08.017.
3
Analyzing the aggregation of polyglutamine-expansion proteins and its modulation by molecular chaperones.分析聚谷氨酰胺扩展蛋白的聚集及其被分子伴侣的调节。
Methods. 2011 Mar;53(3):267-74. doi: 10.1016/j.ymeth.2010.12.035. Epub 2010 Dec 30.
4
Yeast as a platform to explore polyglutamine toxicity and aggregation.酵母作为探索多聚谷氨酰胺毒性和聚集的平台。
Methods Mol Biol. 2013;1017:153-61. doi: 10.1007/978-1-62703-438-8_11.
5
Suppression of polyglutamine-induced cytotoxicity in Saccharomyces cerevisiae by enhancement of mitochondrial biogenesis.增强线粒体生物发生抑制酿酒酵母中多聚谷氨酰胺诱导的细胞毒性。
FASEB J. 2010 May;24(5):1431-41. doi: 10.1096/fj.09-148601. Epub 2009 Dec 14.
6
N-terminal polyglutamine-containing fragments inhibit androgen receptor transactivation function.含N端多聚谷氨酰胺的片段抑制雄激素受体的反式激活功能。
Biol Chem. 2008 Dec;389(12):1455-66. doi: 10.1515/BC.2008.169.
7
Sir2 is induced by oxidative stress in a yeast model of Huntington disease and its activation reduces protein aggregation.Sir2 可被氧化应激诱导,在亨廷顿病的酵母模型中,其激活可减少蛋白质聚集。
Arch Biochem Biophys. 2011 Jun 1;510(1):27-34. doi: 10.1016/j.abb.2011.04.002. Epub 2011 Apr 13.
8
Huntington toxicity in yeast model depends on polyglutamine aggregation mediated by a prion-like protein Rnq1.酵母模型中的亨廷顿毒性取决于由类朊病毒蛋白Rnq1介导的聚谷氨酰胺聚集。
J Cell Biol. 2002 Jun 10;157(6):997-1004. doi: 10.1083/jcb.200112104.
9
Growth assays to assess polyglutamine toxicity in yeast.用于评估酵母中多聚谷氨酰胺毒性的生长测定法。
J Vis Exp. 2012 Mar 5(61):e3461. doi: 10.3791/3461.
10
Polyglutamine expansion mutation yields a pathological epitope linked to nucleation of protein aggregate: determinant of Huntington's disease onset.多聚谷氨酰胺扩展突变产生与蛋白聚集核形成相关的病理性表位:亨廷顿病发病的决定因素。
PLoS One. 2007 Jul 25;2(7):e635. doi: 10.1371/journal.pone.0000635.

引用本文的文献

1
Advances in Modeling Polyglutamine Diseases Using Genome Editing Tools.利用基因组编辑工具研究多聚谷氨酰胺疾病的进展。
Cells. 2022 Feb 2;11(3):517. doi: 10.3390/cells11030517.
2
A Liquid to Solid Phase Transition Underlying Pathological Huntingtin Exon1 Aggregation.病理性亨廷顿蛋白外显子 1 聚集的液-固相转变。
Mol Cell. 2018 May 17;70(4):588-601.e6. doi: 10.1016/j.molcel.2018.04.007. Epub 2018 May 10.
3
Multiple discrete soluble aggregates influence polyglutamine toxicity in a Huntington's disease model system.多种离散的可溶性聚集体影响亨廷顿病模型系统中的多聚谷氨酰胺毒性。
Sci Rep. 2016 Oct 10;6:34916. doi: 10.1038/srep34916.
4
Pharmacological tuning of heat shock protein 70 modulates polyglutamine toxicity and aggregation.药物调节热休克蛋白 70 可调节多聚谷氨酰胺毒性和聚集。
ACS Chem Biol. 2012 Sep 21;7(9):1556-64. doi: 10.1021/cb300166p. Epub 2012 Jun 22.
5
Modeling Huntington disease in yeast: perspectives and future directions.在酵母中建模亨廷顿病:观点和未来方向。
Prion. 2011 Oct-Dec;5(4):269-76. doi: 10.4161/pri.18005. Epub 2011 Oct 1.